Ramsay Health Care (FRA:RMY) Debt-to-EBITDA : (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:RMY Ramsay Health Care Ltd FRA:RMY
80 GF Score
Price €34.00
GF Value €24.82
! 9 Warning Signs
View Full Analysis

What is Ramsay Health Care Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Ramsay Health Care's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was €381 Mil. Ramsay Health Care's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was €6,284 Mil. Ramsay Health Care's annualized EBITDA for the quarter that ended in Jun. 2026 was €1,424 Mil. Ramsay Health Care's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 was 4.68.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Ramsay Health Care's Debt-to-EBITDA or its related term are showing as below:

FRA:RMY' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 2.68   Med: 5.95   Max: 7.75
Current: 5.46

During the past 13 years, the highest Debt-to-EBITDA Ratio of Ramsay Health Care was 7.75. The lowest was 2.68. And the median was 5.95.

FRA:RMY's Debt-to-EBITDA is ranked worse than
80.08% of 482 companies
in the Healthcare Providers & Services industry
Industry Median: 2.2 vs FRA:RMY: 5.46

Ramsay Health Care  (FRA:RMY) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Ramsay Health Care Debt-to-EBITDA Related Terms

Ramsay Health Care Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Ramsay Health Care's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ramsay Health Care Debt-to-EBITDA Chart

Ramsay Health Care Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Ramsay Health Care Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

FRA:RMY vs HCA, THC, EHC: Debt-to-EBITDA Comparison

For the Medical Care Facilities subindustry, Ramsay Health Care's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ramsay Health Care Debt-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ramsay Health Care's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Ramsay Health Care's Debt-to-EBITDA falls into.


FRA:RMY
80GF Score
Ramsay Health Care Ltd FRA:RMY
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ramsay Health Care Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Ramsay Health Care's Debt-to-EBITDA for the fiscal year that ended in Jun. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(380.72792792793 + 6283.9801976734) / 1338.0499307398
=4.98

Ramsay Health Care's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(380.72792792793 + 6283.9801976734) / 1424.1156516238
=4.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Jun. 2026) EBITDA data.

Is Ramsay Health Care (FRA:RMY) Overvalued in 2026?

Based on GuruFocus' analysis, Ramsay Health Care stock appears to be overvalued. The current stock price of €34.00 is trading 37% above its estimated GF Value™ of €24.82.

Key valuation signals for FRA:RMY:

  • Debt-to-EBITDA:
  • GF Value™: €24.82 vs. price of €34.00 (37% above fair value)
  • GF Score™: 80/100 with 9 warning signs

No single metric tells the full story. See the FRA:RMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ramsay Health Care Business Description

Address 126 Phillip Street, Suite 18.03, Level 18, Deutsche Bank Place, Sydney, NSW, AUS, 2000
Ramsay Health Care is one of the largest private healthcare providers in the world, with more than 500 sites across about eight countries. The key markets in which it operates are Australia, France, the UK, and Sweden. It is the largest private hospital group in each of these markets except for the UK, where it is the largest independent supplier to the NHS. Ramsay Santé, which operates the European regions other than the UK, is a 53%-owned subsidiary of Ramsay Health Care. The company typically earns about two-thirds of consolidated earnings in Australia. Ramsay Health Care undertakes both private and publicly funded healthcare.
80GF Score

Get the complete analysis for FRA:RMY

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€34.00
Price
€24.82
GF Value